medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Number 2

<< Back Next >>

Rev Gastroenterol Mex 2007; 72 (2)

Diffuse esophageal spasm (DES). Practical concepts of diagnosis and treatment

Almansa C, Achem SR

Language: Spanish
References: 94
Page: 136-145
PDF size: 160.79 Kb.


ABSTRACT

Diffuse esophageal spasm (DES) is a motility disorder of undetermined etiology, typically presenting with chest pain, dysphagia or both. The aim of this paper is to provide a critical review of the prevalence, pathogenesis, diagnosis and therapy of DES. Data from referral centers indicates that this is a rare disorder with a prevalence of 4-7%. The diagnosis is based on the combination of typical symptoms, radiological findings and manometry (simultaneous contractions (SC) in the distal esophagus in ≥ 20% of wet swallows mixed with normal peristalsis). The pathogenesis remains poorly understood. Recent evidence suggests that nitric oxide deficiency may explain the SC that characterizes this condition at manometry. Gastroesophageal reflux (GER) can coexist in DES and GER has also been implied in the pathogenesis of DES. Whether patients with DES and GER represent a subtype of DES with a different prognosis or outcome is unknown. We present a critical appraisal regarding different therapeutic approaches available for DES and conclude suggesting a management algorithm based on current available literature.


REFERENCES

  1. Osgood H. A peculiar form of oesophagismus. Boston M SJ 1889; 120: 401-5.

  2. Moersch HJ, Camp JD. Diffuse spasm of the lower part of the esophagus. Ann Otol Rhinol Laryngol 1934; 43: 1165.

  3. Van Exter P, Keet AD. Curling of the esophagus. S Afr Med J 1954; 28: 206.

  4. Creamer B, Donoghue FE, Code CF. Pattern of esophageal motility in diffuse spasm. Gastroenterology 1958; 34: 782-96.

  5. Roth and Fleshler. Diffuse esophageal spasm. Ann Intern Med 1964; 61: 914-23.

  6. Richter JE, Wu WC, Johns DN, Blackwell JN, Nelson JL, Castell JA, Castell DO. Esophageal manometry in 95 healthy adult volunteers: Variability of pressures with age and frequency of “abnormal” contractions. Dig Dis Sci 1987; 32(6): 583-92.

  7. Richter JE, Castell DO. Diffuse esophageal spasm: A reappraisal. Ann Intern Med 1984; 100: 242-5.

  8. Pandolfino JE, Kahrilas PJ. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 2005; 128: 209-24.

  9. Dalton CB, Castell D, Hewson EG, Wallace C, Richter JE. Diffuse esophageal spasm a rare motility disorder not characterized by high amplitude contractions. Dig Dis Sci 1991; 36(8): 1025-8.

  10. Dekel R, Pearson T, Wendel C, De Garmo P, Fennerty MB, Fass R. Assessment of esophageal motor function in patients with dysphagia or chest pain. The clinical outcomes research initiative experience. Aliment Pharmacol Ther 2003; 18: 1083-9.

  11. Ott DJ, Abernethy WB, Chen WY, Wu WC, Gelfand DW. Radiographic evaluation of esophageal motility: results in 170 patients with chest pain. AJR 1990; 155: 983-5.

  12. ChenYM, Ott DJ, Hewson EG, Richter JE, Wu WC, Gelfand DW, Castell DO. Diffuse esophageal spasm: radiographic and manometric correlation. Radiology 1989; 170: 807-10.

  13. Bassotti G, Pelli MA, Morelli A. Clinical and manometric aspects of diffuse esophageal spasm in a cohort of subjects evaluated for dysphagia and/or chest pain. Am J Med Sci 1990; 300(3): 148-51.

  14. Spechler, Castell DO. Classification of esophageal motility abnormalities. Gut 2001; 49: 145-51.

  15. Achem SR, Benjamin SB. Esophageal dismotility (spastic dismotility). In: Castell DO (ed.). The esophagus. 2nd. Ed. Boston: Little, Brown and Company; 1995, p. 247-68.

  16. Reinig JW, Stanley JH, Schabel SI. CT Evaluation of thickened esophageal walls. AJR 1983; 140: 931-4.

  17. Byrnes CK. Muscular hypertrophy of lower esophagus, read before the Societe International de Chirugie, Rome, October 1963.

  18. Eypasch E, DeMeester TR, Klingman RR, Stein HJ. Physiologic assessment and surgical management of diffuse esophageal spasm. J Thoracic Cardiovasc Surg 1992; 104(4): 859-69.

  19. Henderson RD, Ryder D, Marryatt G. Extended esophageal myotomy and short total fundoplication hernia repair in diffuse esophageal spasm: five year review in 34 patients. Ann Thorac Surg 1987; 43(1): 25-31.

  20. Flye MW, Sealy WC. Diffuse spasm of the esophagus. Ann Thorac Surg 1975; 19(6): 677-87.

  21. Friesen DL, Henderson RD, Hanna W. Ultrastructure of the esophageal muscle in achalasia and diffuse esophageal spasm. Am J Clin Path 1983. 79(3): 319-25.

  22. Champion JK, Delisle N, Hunt T. Myenteric plexus in spastic motility disorders J Gastrointest Surg 2001; 5(5): 514-16.

  23. Cassella RR, Ellis FH, Brown AL. Diffuse spasm of the lower part of the esophagus. Fine structure of esophageal smooth muscle and nerve. JAMA 1965; 191(5): 379-82.

  24. Behar J, Biancani P. Pathogenesis of simultaneous esophageal contractions in patients with esophageal motility disorders. Gastroenterology 1993; 105: 111-18.

  25. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL. The effect of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995: 109: 1241-8.

  26. Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm a malfunction that involves nitric oxide. Scand J Gastroenterol 1995; 30: 1041-5.

  27. Jones CM. Digestive tract pain. New York: Macmillan; 1938.

  28. Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer RC, Petrie DJ. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256-67.

  29. Bombeck CT, Battle WS, Nyhuss LM. Spasm in the differential diagnosis of gastroesophageal reflux. Arch Surg 1972; 104: 477-83.

  30. Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977; 72(1): 23-7.

  31. Campo S, Traube M. Manometric characteristics in idiopathic and reflux-associated esophageal spasm. Am J Gastroenterol 1992: 87(2): 187-9.

  32. Hayashi H, Mine K, Hosoi M, Tsuchida O, Handa M, Kinukawa N, Andou K, Kubo C. Comparison of the esophageal manometric characteristics of idiopathic and reflux-associated esophageal spasm: evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Dig Dis Sci 2003; 48(11): 2124-31.

  33. Dogan I, Puckett JL, Padda BS, Mittal RK. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol 2007; 102(1): 137-45.

  34. Mittal RK, Liu J, Puckett JL, Bhalla V, Bhargava V, Tipnis N, Kassab G. Sensory and motor function of the esophagus: lessons from ultrasound imaging. Gastroenterology 2005; 128(2): 487-97.

  35. Mittal RK, Bhalla V. Oesophageal motor functions and its disorders. Gut 2004; 53(10): 1536-42.

  36. Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, Nishioka M. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol 2001; 96(7): 2026-32.

  37. Ascaso JF, Herreros B, Sanchiz V, Lluch I, Real JT, Minguez M, et al. Oesophageal motility disorders in type 1 diabetes mellitus and their relation to cardiovascular autonomic neuropathy. Neurogastroenterol Motil 2006; 18(9): 813-22.

  38. Burakoff R, Rubinow A, Cohen AS. Esophageal manometry in familial amyloid polyneuropathy. Am J Med 1985; 79(1): 85-9.

  39. Rubinow A, Burakoff R, Cohen AS, Harris LD. Esophageal manometry in systemic amyloidosis. A study of 30 patients. Am J Med 1983; 75(6): 951-6.

  40. Crozier RE, Glick ME, Gibb SP, Ellis FH, Veerman JM. Acid-provoked esophageal spasm as a cause of non-cardiac chest pain. Am J Gastroenterol 1991; 86(11): 1576-80.

  41. Achem SR, Kolts BE, MacMath T, Richter J, Mohr D, Burton L, Castell DO. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42(10): 2138-45.

  42. Bautista J, Fullerton H, Briseno M, Cui H, Fass R. The effect of an empirical trial of high dose lansoprazole on symptom response of patients with noncardiac chest pain a randomized, double-blind pacebo controlled crossover trial. Aliment Pharmacol Ther 2004; 19: 1123-30.

  43. Dickman R, Emmons S, Cui H, Sewell J, Hernandez D, Esquivel RF, Fass R. The effect of a therapeutic trial of high dose rabeprazole on symptom response of patients with non cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2005; 22: 547-55.

  44. Field CE. Octyl nitrite in achalasia of the cardia. Lancet 1944; 848-51.

  45. Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289(1): 23-5.

  46. Kikendall JW, Mellow MH. Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility. Gastroenterology 1980; 79(4): 703-6.

  47. Parker WA, MacKinnon GL. Nitrites in the treatment of diffuse esophageal spasm. Drug Intell Clin Pharm 1981; 15(10): 806-7.

  48. Moreland RB, Goldstein I, Traish A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sci 1998; 62(20): 309-18.

  49. Bortolotti M, Mari C, Giovannini M, Pinna S, Miglioli M, Pandolfo N. Effects of sildenafil on esophageal motility of normal subjects. Dig Dis Sci 2001; 46(11): 2301-6.

  50. Eherer AJ, Schwetz I, Hammer HF, Petnehazy T, Scheidl SJ, Weber K, Krejs GJ. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50(6): 758-64.

  51. Agrawal A, Tutuian R, Hila A, Castell DO. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report. Dig Dis Sci 2005; 50(11): 2059-62.

  52. Dodds WJ, Dent J, Hogan WJ, Arndofer RC. Effect of atropine on esophageal motor function in humans. Am J Physiol 1981; 240: G290-6.

  53. Phaosawasdi K, Malmud LS, Tolin RD, Stelzer F, Applegate G, Fisher RS. Cholinergic effects on esophageal transit and clearance. Gastroenterology 1981; 81: 915-20.

  54. Erckenbretch E, Berges W, Sonnenberg A. The effects of pirenzepine on esophageal motility. Scand J Gastroenterol 1982; 72: 185-90.

  55. Triadafilopoulos G, Tsang HP. Olfactory stimuli provoke diffuse esophageal spasm: reversal by ipratropium bromide. Am J Gastroenterol 1996; 91(10): 2224-9.

  56. Castell DO. Calcium-channel blocking agents for gastrointestinal disorders. Am J Cardiol 1985; 55(3): 210B-3B.

  57. Richter JE, Dalton CB, Buice RG, Castell DO. Nifedipine: a potent inhibitor of contractions in the body of the human esophagus. Studies in healthy volunteers and patients with the nutcracker esophagus. Gastroenterology 1985; 85: 549-54.

  58. Konrad DI, Baunack AR, Ramsch KD, Ahr G, Kraft H, Schmitz H, et al. Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J Clin Pharmacol 1991; 41(4): 313-6.

  59. Blackwell JN, Holt S, Heading RC. Effect of nifedipine on oesophageal motility and gastric emptying. Digestion 1981; 21(1): 50-6.

  60. Nasrallah SM. Nifedipine in the treatment of diffuse oesophageal spasm. Lancet 1982; 2(8310): 1285.

  61. Nasrallah SM, Tommaso CL, Singleton RT, Backhaus EA. Primary esophageal motor disorders: clinical response to nifedipine. South Med J 1985; 78(3): 312-5.

  62. Thomas E, Witt P, Willis M, Morse J. Nifedipine therapy for diffuse esophageal spasm. South Med J 1986; 79(7): 847-9.

  63. Davies HA, Lewis MJ, Rhodes J, Henderson AH. Trial of nifedipine for prevention of oesophageal spasm. Digestion 1987; 36(2): 81-3.

  64. Banciu T, Iova M, Biroasiu G, Susan L. The diagnostic and therapeutic contribution of calcium channel inhibitors (nifedipine) in esophageal spasm. Med Interne 1990; 28(1): 69-71.

  65. Richter JE, Spurling TJ, Cordova CM, Castell DO. Effects of oral calcium blockers on esophageal contractions. studies on volunteers and patient with nutcracker esophagus. Dig Dis Sci 1984; 29: 649-56.

  66. Drenth JP, Bos LP, Engels LG. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990; 4(4): 411-16.

  67. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845-52.

  68. Shapiro LM, Crake T, Poole WPA. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterization. Br Med J (Clin Res Ed) 1988; 296(6616): 170-1.

  69. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330(20): 1411-17.

  70. Clouse RE, Lustman PJ. Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 1983; 309(22): 1337-42.

  71. Song CW, Lee SJ, Jeen YT, Chun HJ, Um SH, Kim CD, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol 2001; 96(8): 2312-16.

  72. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987; 92(4): 1027-36.

  73. Handa M, Mine K, Yamamoto H, Hayashi H, Tsuchida O, Kanazawa F, Kubo C. Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol 1999; 28(3): 228-32.

  74. Broekaert D, Fischler B, Sifrim D, Janssens J, Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor, on esophageal hypersensivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2006; 23: 365-70.

  75. Varia I, Logue E, O’Connor C, Newby K, Wagner R, Davenport C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367-72.

  76. Friedenberg F, Gollamudi S, Parkman HP. The use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004; 49(2): 165-75.

  77. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med 1994; 121(8): 590-1.

  78. Miller LS, Parkman HP, Schiano TD, Cassidy MJ, Ter RB, Dabezies MA, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41(10): 2025-31.

  79. Cassidy MJ, Schiano TD, Adrain AL, Parkman HP, Cohen S, Fisher RS, et al. Botulinum toxin injection for the treatment of symptomatic diffuse esophageal spasm. Am J Gastroenterol 1996; 91(9): A1884.

  80. Nebendahl JC, Brand B, Von Schrenck T, Matsui U, Thonke F, Bohnacker S, et al. Effective treatment of diffuse esophageal spasm (DES) by endoscopic injection of botulinum toxin. Gastroenterology 1998; 114(4): A240.

  81. Nebendahl JC, Brand B, Von Schrenck T, Matsui U, Sriram PVJ, Bohnacker S, et al. Treatment of diffuse esophageal spasm with botulinum toxin: a prospective study with 6 months follow up. Gastrointest Endosc 1999; 49(4): AB129.

  82. Storr M, Allescher HD, Rosch T, Born P, Weigert N, Classen M. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54(6): 754-9.

  83. Miller LS, Pullela SV, Parkman HP, Schiano TD, Cassidy MJ, Cohen S, Fisher RS. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97(7): 1640-6.

  84. Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997; 42(4): 724-7.

  85. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 23; 332(12): 774-8.

  86. Patti MG, Feo CV, Arcerito M, De Pinto M, Tamburini A, Diener U, et al. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci 1999; 44(11): 2270-6.

  87. Smith CD, Stival A, Howell DL, Swafford V. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg 2006; 243(5): 579-84.

  88. Ebert EC, Ouyang A, Wright SH, Cohen S, Lipshutz WH. Pneumatic dilatation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci 1983; 28(6): 481-5.

  89. Irving JD, Owen WJ, Linsell J, McCullagh M, Keightley A, Anggiansah A. Management of diffuse esophageal spasm with balloon dilatation. Gastrointest Radiol 1992; 17(3): 189-92.

  90. Ellis FH. Esophagomyotomy for noncardiac chest pain resulting from diffuse esophageal spasm and related disorders. Am J Med 1992; 92(5A): 129S-31S.

  91. Champion JK, Delisle N, Hunt T. Comparison of thoracoscopic and laparoscopic esophagomyotomy with fundoplication for primary motility disorders. Eur J Cardiothorac Surg 1999; 16 Suppl 1: S34-6.

  92. Patti MG, Gorodner MV, Galvani C, Tedesco P, Fisichella PM, Ostroff JW, et al. Spectrum of esophageal motility disorders: Implications for diagnosis and treatment. Arch Surg 2005; 140: 442-9.

  93. Patti MG, Pellegrini CA, Arcerito M, Tong J, Mulvihill SJ, Way LW. Comparison of medical and minimally invasive surgical therapy for primary esophageal motor disorders. Arch Surg 1995; 130(6): 609-16.

  94. McBride PJ, Hindder RA, Filipi C, Raiser F, Katada N, Lund RJ. Surgical treatment of spastic conditions of the esophagus. Int J Surg 1997; 82: 113-18.




2020     |     www.medigraphic.com